These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence. Bichelmeier U; Schmidt T; Hübener J; Boy J; Rüttiger L; Häbig K; Poths S; Bonin M; Knipper M; Schmidt WJ; Wilbertz J; Wolburg H; Laccone F; Riess O J Neurosci; 2007 Jul; 27(28):7418-28. PubMed ID: 17626202 [TBL] [Abstract][Full Text] [Related]
11. Mouse models of Machado-Joseph disease and other polyglutamine spinocerebellar ataxias. Colomer Gould VF NeuroRx; 2005 Jul; 2(3):480-3. PubMed ID: 16389311 [TBL] [Abstract][Full Text] [Related]
12. CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3. Mueller T; Breuer P; Schmitt I; Walter J; Evert BO; Wüllner U Hum Mol Genet; 2009 Sep; 18(17):3334-43. PubMed ID: 19542537 [TBL] [Abstract][Full Text] [Related]
13. A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration. Goti D; Katzen SM; Mez J; Kurtis N; Kiluk J; Ben-Haïem L; Jenkins NA; Copeland NG; Kakizuka A; Sharp AH; Ross CA; Mouton PR; Colomer V J Neurosci; 2004 Nov; 24(45):10266-79. PubMed ID: 15537899 [TBL] [Abstract][Full Text] [Related]
14. CDK5 protects from caspase-induced Ataxin-3 cleavage and neurodegeneration. Liman J; Deeg S; Voigt A; Voßfeldt H; Dohm CP; Karch A; Weishaupt J; Schulz JB; Bähr M; Kermer P J Neurochem; 2014 Jun; 129(6):1013-23. PubMed ID: 24548080 [TBL] [Abstract][Full Text] [Related]
15. [Polyglutamine-expanded ataxin-3 is degraded by autophagy]. Xiao H; Tang J; Hu Z; Tan J; Tang B; Jiang Z Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):23-8. PubMed ID: 20140862 [TBL] [Abstract][Full Text] [Related]
16. In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis. Williams AJ; Knutson TM; Colomer Gould VF; Paulson HL Neurobiol Dis; 2009 Mar; 33(3):342-53. PubMed ID: 19084066 [TBL] [Abstract][Full Text] [Related]
17. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies. Kumada S; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Oda M J Neuropathol Exp Neurol; 2002 Nov; 61(11):984-91. PubMed ID: 12430715 [TBL] [Abstract][Full Text] [Related]
18. Polyglutamine-induced neurodegeneration in SCA3 is not mitigated by non-expanded ataxin-3: conclusions from double-transgenic mouse models. Hübener J; Riess O Neurobiol Dis; 2010 Apr; 38(1):116-24. PubMed ID: 20079840 [TBL] [Abstract][Full Text] [Related]